Jonathan E. Lim

Insider Reports History

Location
San Diego, CA
Signature
/s/ Ebun Garner, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan E. Lim:

Form 4 holding Chairman & CEO, Director, 10%+ Owner

Erasca, Inc.

Security class
Stock option (right to buy)
Shares / value
2,000,000
Estimated value
Report date
29 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Common Stock
Shares / value
307,956
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Form 4 holding Director

Boundless Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
24,000
Estimated value
Report date
23 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jonathan E. Lim

4 ERAS

Erasca, Inc.

Report period
20 Jul 2021
Transactions
6
Transaction value
$0
Filing time
20 Jul 2021, 20:58
Role
Chairman and Chief Executive Officer, Director, 10%+ Owner
Next action
Open filing details
3 ERAS

Erasca, Inc.

Report period
15 Jul 2021
Transactions
0
Transaction value
$0
Filing time
15 Jul 2021, 21:32
Role
Chairman and CEO Exhibit List: 24 - Power of Attorney, Director, 10%+ Owner
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .